Actio Biosciences

Actio Biosciences is a San Diego-based clinical-stage biotechnology company developing precision medicines that translate insights from Mendelian (single-gene) genetics into treatments for both rare and common diseases. Its pipeline targets genetically defined conditions including KCNT1-related epilepsy and TRPV4-related Charcot-Marie-Tooth disease type 2C (CMT2C), following a strategy of expanding from rare indications into more prevalent diseases that share the same underlying biology. The company is backed by Canaan Partners. Actio publishes no developer or API surface; this profile captures its public identity and corporate web properties.

Actio Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Precision Medicine, Genetics, and Rare Diseases.

Actio Biosciences’ developer surface includes engineering blog and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

11.4/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyPrecision MedicineGeneticsRare DiseasesDrug DiscoveryPharmaceutical

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 11.4/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.4 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/actio-biosciences: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 3

The organization behind the API

Website

Website

About

About

Blog

Blog

Source (apis.yml)

aid: actio-biosciences
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/actio-biosciences.png
name: Actio Biosciences
description: Actio Biosciences is a San Diego-based clinical-stage biotechnology company developing precision medicines that
  translate insights from Mendelian (single-gene) genetics into treatments for both rare and common diseases. Its pipeline
  targets genetically defined conditions including KCNT1-related epilepsy and TRPV4-related Charcot-Marie-Tooth disease type
  2C (CMT2C), following a strategy of expanding from rare indications into more prevalent diseases that share the same underlying
  biology. The company is backed by Canaan Partners. Actio publishes no developer or API surface; this profile captures its
  public identity and corporate web properties.
url: https://raw.githubusercontent.com/api-evangelist/actio-biosciences/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Precision Medicine
- Genetics
- Rare Diseases
- Drug Discovery
- Pharmaceutical
apis: []
common:
- type: Website
  url: https://actiobiosciences.com/
- type: About
  url: https://actiobiosciences.com/about/
- type: Blog
  url: https://actiobiosciences.com/category/press-releases/
- type: PrivacyPolicy
  url: https://actiobiosciences.com/privacy
- type: TermsOfService
  url: https://actiobiosciences.com/terms-of-use
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence